Oncology

New study suggests that vitamin D supplements may significantly extend the treatment-free survival period for patients with asymptomatic chronic lymphocytic leukaemia

A recent trial has shown that telehealth delivery of early palliative care is as effective as in-person visits for patients with advanced non-small cell lung cancer

A Phase 3 trial reveals that osimertinib significantly extends progression-free survival in patients with unresectable stage III EGFR-mutant non-small cell lung cancer after chemoradiotherapy

Recent research indicates heightened cardiovascular risks when combining androgen receptor signalling inhibitors with androgen deprivation therapy in prostate cancer treatment.

A study reports of a new surgical platform capable of identifying isocitrate dehydrogenase mutations in gliomas in under two minutes.

A recent study found that perioperative FLOT chemotherapy significantly improves survival rates in patients with esophageal adenocarcinoma.

Read results from a trial presented as ASCO 2024, which details the impact that Isa-VRd therapy has in multiple myeloma patients

Read the latest news from ASCO 2024, including on results from the ADRIATIC trial on small-cell lung cancer post-chemoradiotherapy.